
	Mr. Sarney is an accomplished finance and accounting professional with over 15 years of experience in the biotechnology industry in both early-stage and publicly traded companies. Prior to joining Avaxia, he worked as a consultant from 2009 to 2013 at various biotechnology and medical device companies in interim VP of Finance and Controller roles. Prior to working as a consultant, Mr. Sarney was the Corporate Controller and Principal Accounting Officer of Nitromed, Inc., a publicly traded cardiovascular-focused pharmaceutical company. During his time at Nitromed, Mr. Sarney was responsible for SEC reporting, financial planning, risk management, treasury, the initiation of the company&#39;s Sarbanes-Oxley compliance efforts, and financial and accounting support for the launch of the company&rsquo;s first product, BiDil. During his career, he has also held the position of audit supervisor within the technology assurance group of PricewaterhouseCoopers LLP. Mr. Sarney earned a B.S. in business management from the University of Hartford, an M.B.A. from Boston University and an M.A. in accounting from Suffolk University. Mr. Sarney is a certified public accountant in the state of Massachusetts.
